E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 8/23/2005 in the Prospect News Biotech Daily.

Santarus EPS estimates revised by Thomas Weisel

Santarus Inc. was reiterated by Thomas Weisel Partners analyst Donald Ellis at an overweight rating with a price target on the stock of $17 per share following its $31.2 million PIPEs transaction. EPS estimates also were revised to a loss of $1.92 from a loss of $1.75 for 2005. Santarus shares Tuesday were up $0.11, or 2.18%, at $5.15 on volume of 238,786 shares versus the three-month running average of 247,228 shares.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.